Sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses, cattle, pigs and dogs

Negara: Irlandia

Bahasa: Inggris

Sumber: HPRA (Health Products Regulatory Authority)

Beli Sekarang

Unduh Karakteristik produk (SPC)
04-04-2020

Bahan aktif:

Metamizole sodium monohydrate; Hyoscine butylbromide

Tersedia dari:

Dechra Regulatory B.V.

Kode ATC:

QA03DB04

INN (Nama Internasional):

Metamizole sodium monohydrate; Hyoscine butylbromide

Dosis:

500, 4 milligram(s)/millilitre

Bentuk farmasi:

Solution for injection

Jenis Resep:

POM: Prescription Only Medicine as defined in relevant national legislation

Area terapi:

butylscopolamine and analgesics

Status otorisasi:

Authorised

Tanggal Otorisasi:

2019-06-26

Karakteristik produk

                                Health Products Regulatory Authority
03 April 2020
CRN009P51
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses,
cattle, pigs and dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
​
ACTIVE SUBSTANCES:
​
​
Metamizole sodium monohydrate
​500.0 mg
​
(equivalent to 443 mg metamizole)
​
​
​
​
Hyoscine butylbromide
​4.0 mg
​
(equivalent to 2.76 mg hyoscine)
​
​
​
​
EXCIPIENTS:
​
​
Phenol
​5.0 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, cattle, pigs, dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Horses, cattle, pigs, dogs: treatment of smooth muscle spasms and pain
associated with underlying disorders of the
gastro-intestinal tract, urogenital system and bile excretory organs.
Horses only: Spasmodic colics.
Cattle, pigs, dogs: Supportive therapy for acute diarrhoea and
gastroenteritis.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or to
any of the excipients.
Do not use in cases of:
- gastro-intestinal ulceration
- chronic gastro-intestinal disorders
- mechanic obstruction in the gastro-intestinal system
- paralytic ileus
- disorders of the haematopoietic system
- coagulopathies
- renal insufficiency
- tachyarrhythmia
- glaucoma
- prostate adenoma.
Health Products Regulatory Authority
03 April 2020
CRN009P51
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to the risk of anaphylactic shock, metamizole-containing solutions
should be administered slowly when given
intravenously.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
In a very small number of people, metamizole can cause reversible, but
potentially serious agranulocytosis and other rea
                                
                                Baca dokumen lengkapnya